98 related articles for article (PubMed ID: 17489854)
1. The Ala53Thr mutation in the alpha-synuclein gene in a Korean family with Parkinson disease.
Ki CS; Stavrou EF; Davanos N; Lee WY; Chung EJ; Kim JY; Athanassiadou A
Clin Genet; 2007 May; 71(5):471-3. PubMed ID: 17489854
[No Abstract] [Full Text] [Related]
2. Letter to the editor on "Threonine 53 in alpha-synuclein is conserved in long-living non-primate animals".
Hamilton BA
Biochem Biophys Res Commun; 2010 Jan; 391(1):1154. PubMed ID: 19903454
[No Abstract] [Full Text] [Related]
3. Allelic imbalance of expression and epigenetic regulation within the alpha-synuclein wild-type and p.Ala53Thr alleles in Parkinson disease.
Voutsinas GE; Stavrou EF; Karousos G; Dasoula A; Papachatzopoulou A; Syrrou M; Verkerk AJ; van der Spek P; Patrinos GP; Stöger R; Athanassiadou A
Hum Mutat; 2010 Jun; 31(6):685-91. PubMed ID: 20340137
[TBL] [Abstract][Full Text] [Related]
4. alpha-Synuclein locus triplication causes Parkinson's disease.
Singleton AB; Farrer M; Johnson J; Singleton A; Hague S; Kachergus J; Hulihan M; Peuralinna T; Dutra A; Nussbaum R; Lincoln S; Crawley A; Hanson M; Maraganore D; Adler C; Cookson MR; Muenter M; Baptista M; Miller D; Blancato J; Hardy J; Gwinn-Hardy K
Science; 2003 Oct; 302(5646):841. PubMed ID: 14593171
[No Abstract] [Full Text] [Related]
5. Genetic analysis of families with Parkinson disease that carry the Ala53Thr mutation in the gene encoding alpha-synuclein.
Athanassiadou A; Voutsinas G; Psiouri L; Leroy E; Polymeropoulos MH; Ilias A; Maniatis GM; Papapetropoulos T
Am J Hum Genet; 1999 Aug; 65(2):555-8. PubMed ID: 10417297
[No Abstract] [Full Text] [Related]
6. alpha-Synuclein gene duplications in sporadic Parkinson disease.
Theuns J; Van Broeckhoven C
Neurology; 2008 Jan; 70(1):7-9. PubMed ID: 18166703
[No Abstract] [Full Text] [Related]
7. Alpha-synuclein multiplications with parkinsonism, dementia or progressive myoclonus?
Puschmann A; Wszolek ZK; Farrer M; Gustafson L; Widner H; Nilsson C
Parkinsonism Relat Disord; 2009 Jun; 15(5):390-2. PubMed ID: 18824390
[TBL] [Abstract][Full Text] [Related]
8. [Relationship between alpha-synuclein and Parkinson's disease].
Nishioka K; Hattori N
Brain Nerve; 2007 Aug; 59(8):825-30. PubMed ID: 17713118
[TBL] [Abstract][Full Text] [Related]
9. Re: Alpha-synuclein gene duplication is present in sporadic Parkinson disease.
Troiano AR; Cazeneuve C; Le Ber I; Bonnet AM; Lesage S; Brice A
Neurology; 2008 Oct; 71(16):1295; author reply 1295. PubMed ID: 18852449
[No Abstract] [Full Text] [Related]
10. Re: Alpha-synuclein gene duplication is present in sporadic Parkinson disease.
Brueggemann N; Odin P; Gruenewald A; Tadic V; Hagenah J; Seidel G; Lohmann K; Klein C; Djarmati A
Neurology; 2008 Oct; 71(16):1294; author reply 1294. PubMed ID: 18852448
[No Abstract] [Full Text] [Related]
11. alpha-Synuclein and Parkinson disease susceptibility.
Winkler S; Hagenah J; Lincoln S; Heckman M; Haugarvoll K; Lohmann-Hedrich K; Kostic V; Farrer M; Klein C
Neurology; 2007 Oct; 69(18):1745-50. PubMed ID: 17872362
[TBL] [Abstract][Full Text] [Related]
12. Oxidative-stress-induced apoptosis in PBLs of two patients with Parkinson disease secondary to alpha-synuclein mutation.
Battisti C; Formichi P; Radi E; Federico A
J Neurol Sci; 2008 Apr; 267(1-2):120-4. PubMed ID: 18061619
[TBL] [Abstract][Full Text] [Related]
13. Cardiac sympathetic denervation in Parkinson's disease linked to SNCA duplication.
Orimo S; Uchihara T; Nakamura A; Mori F; Ikeuchi T; Onodera O; Nishizawa M; Ishikawa A; Kakita A; Wakabayashi K; Takahashi H
Acta Neuropathol; 2008 Nov; 116(5):575-7. PubMed ID: 18751989
[No Abstract] [Full Text] [Related]
14. Gene dosage analysis of alpha-synuclein (SNCA) in patients with Parkinson's disease.
Deng H; Xie W; Guo Y; Le W; Jankovic J
Mov Disord; 2006 May; 21(5):728-9. PubMed ID: 16552756
[No Abstract] [Full Text] [Related]
15. Rescue of alpha-synuclein cytotoxicity by insulin-like growth factors.
Kao SY
Biochem Biophys Res Commun; 2009 Jul; 385(3):434-8. PubMed ID: 19470380
[TBL] [Abstract][Full Text] [Related]
16. Controlling aggregation propensity in A53T mutant of alpha-synuclein causing Parkinson's disease.
Kumar S; Sarkar A; Sundar D
Biochem Biophys Res Commun; 2009 Sep; 387(2):305-9. PubMed ID: 19580781
[TBL] [Abstract][Full Text] [Related]
17. Solid-state NMR reveals structural differences between fibrils of wild-type and disease-related A53T mutant alpha-synuclein.
Heise H; Celej MS; Becker S; Riedel D; Pelah A; Kumar A; Jovin TM; Baldus M
J Mol Biol; 2008 Jul; 380(3):444-50. PubMed ID: 18539297
[TBL] [Abstract][Full Text] [Related]
18. Aggregation-defective alpha-synuclein mutants inhibit the fibrillation of Parkinson's disease-linked alpha-synuclein variants.
Koo HJ; Choi MY; Im H
Biochem Biophys Res Commun; 2009 Aug; 386(1):165-9. PubMed ID: 19501571
[TBL] [Abstract][Full Text] [Related]
19. The alpha-synuclein gene and Parkinson disease in a Chinese population.
Chan DK; Mellick G; Cai H; Wang XL; Ng PW; Pang CP; Woo J; Kay R
Arch Neurol; 2000 Apr; 57(4):501-3. PubMed ID: 10768624
[TBL] [Abstract][Full Text] [Related]
20. Parkinson syndrome, neuropathy, and myopathy caused by the mutation A8344G (MERRF) in tRNALys.
Horvath R; Kley RA; Lochmüller H; Vorgerd M
Neurology; 2007 Jan; 68(1):56-8. PubMed ID: 17200493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
